Medical and Pharmaceutical Australian biotech uncovers broader view of tumour genetics with liquid biopsy The team developed the study in collaboration with US sequencing company Illumina Joseph MortonJune 17, 2025
Medical and Pharmaceutical Supernus Pharmaceuticals picks up embattled Sage Therapeutics Acquiring Sage expands Supernus’s presence in nonpsychiatric conditions Joseph MortonJune 16, 2025
Medical and Pharmaceutical Lung cancer screening truck heads for remote mining towns in Western Australia It is the first in the state to offer low-dose CT scans in isolated communities Rowan DunneJune 16, 2025
Medical and Pharmaceutical IceCure Medical takes another step towards a full patent application in US IceCure continues expanding its intellectual property portfolio to strengthen its cryoablation platform Joseph MortonJune 10, 2025
Medical and Pharmaceutical Breath Diagnostics opens Respiratory Innovation Summit with captivating presentation It was an honour for the company to be selected to kick off this prestigious event Rowan DunneJune 9, 2025
Medical and Pharmaceutical QuidelOrtho seeks FDA approval to complete acquisition of LEX Diagnostics LEX Diagnostics develops molecular diagnostics to improve patient care by delivering clinical insights Joseph MortonJune 6, 2025
Medical and Pharmaceutical Dying woman blames CT scan technicians for cancer spread, files lawsuit Their failure to properly interpret the results will cost her life, she claims Rowan DunneJune 6, 2025
Medical and Pharmaceutical The NHS in England introduces innovative new cancer detection options The test will detect a wider range of genetic variants to determine eligibility for targeted treatment Joseph MortonJune 5, 2025
Medical and Pharmaceutical Combining mammograms with lung cancer screening can boost female uptake A recent study from Stanford Medicine made this conclusion Rowan DunneJune 4, 2025
Medical and Pharmaceutical Australia’s first national lung cancer screening program begins in July The aim of the game is to save 12,000 lives by 2035 Rowan DunneJune 3, 2025